Tenax Therapeutics Inc — Cash Flow (NASDAQ:TENX) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities -9.27 M-10.86 M-12.01 M-5.9 M-14.81 M -25.91 M Cash from investing activities 20.11 K452.61 K-2 3232 8430 0 Cash from financing activities 10.6 M9.74 M8.55 M13.57 M99.87 M 26.97 M Free cash flow -9.28 M-10.86 M-12.02 M-5.9 M-14.81 M -25.91 M

Haberler

Tenax Therapeutics: Some Future Potential (NASDAQ:TENX)

Tenax Therapeutics Stock: A Speculative Buy (NASDAQ:TENX)

Tenax: Lower Variance In Phase 3 Has "Loaded The Dice" For An Asymmetric Repricing

Tesla, Goldman Sachs among market cap stock movers on Monday

Tenax Therapeutics’ phase 3 LEVEL study confirms enrollment target

Guggenheim, Tenax Therapeutics için hedef fiyatını 14 dolardan 25 dolara yükseltti

Tenax Therapeutics stock price target raised to $25 from $14 at Guggenheim

Tenax Therapeutics yöneticisi Rich Stuart 50.792 dolar değerinde hisse satın aldı

Tenax Therapeutics director Rich Stuart buys $50,792 in stock

Giordano buys Tenax Therapeutics (TENX) shares worth $19,999

Tenax Therapeutics’in geçici CFO’su McGauley 58.164 dolar değerinde hisse satın aldı

Tenax Therapeutics interim CFO McGauley buys shares worth $58,164